These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15800341)

  • 1. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma (KS): implications for the design of therapeutic trials in patients with advanced symptomatic KS.
    Nasti G; Tirelli U
    J Clin Oncol; 2005 Apr; 23(10):2433; author reply 2433-4. PubMed ID: 15800341
    [No Abstract]   [Full Text] [Related]  

  • 2. Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma.
    Krown SE
    J Clin Oncol; 2004 Feb; 22(3):399-402. PubMed ID: 14752065
    [No Abstract]   [Full Text] [Related]  

  • 3. Paclitaxel for AIDS-associated Kaposi's sarcoma.
    Dhillon T; Stebbing J; Bower M
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
    Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
    J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
    Cheung MC; Pantanowitz L; Dezube BJ
    Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives.
    Vanni T; Sprinz E; Machado MW; Santana Rde C; Fonseca BA; Schwartsmann G
    Cancer Treat Rev; 2006 Oct; 32(6):445-55. PubMed ID: 16860939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of AIDS-related Kaposi's sarcoma.
    Northfelt DW; Kahn JO; Volberding PA
    Hematol Oncol Clin North Am; 1991 Apr; 5(2):297-310. PubMed ID: 2022595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kaposi's sarcoma].
    Imamura A
    Gan To Kagaku Ryoho; 2003 May; 30(5):634-9. PubMed ID: 12795094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
    Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
    AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.
    Nasti G; Martellotta F; Berretta M; Mena M; Fasan M; Di Perri G; Talamini R; Pagano G; Montroni M; Cinelli R; Vaccher E; D'Arminio Monforte A; Tirelli U; ;
    Cancer; 2003 Dec; 98(11):2440-6. PubMed ID: 14635079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma in a nonadherent HAART patient.
    Ball SC
    AIDS Read; 1999; 9(3):170, 173-4. PubMed ID: 12728902
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapidly eruptive, treatment-resistant, nodular Kaposi's sarcoma in an acquired immunodeficiency syndrome (AIDS) patient on highly active antiretroviral therapy.
    Chang CA; Sanchez MR; Karen JK; Rosenman KS; Prystowsky SD
    Int J Dermatol; 2009 Feb; 48(2):173-4. PubMed ID: 19200196
    [No Abstract]   [Full Text] [Related]  

  • 14. [Etiology, pathogenesis and treatment options in Kaposi's sarcoma of HIV infection].
    Simon K
    Przegl Epidemiol; 2001; 55 Suppl 3():129-35. PubMed ID: 11984939
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcoma.
    Stebbing J; Sanitt A; Teague A; Powles T; Nelson M; Gazzard B; Bower M
    J Clin Oncol; 2007 Jun; 25(16):2230-5. PubMed ID: 17470847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil.
    Yoshioka MC; Alchorne MM; Porro AM; Tomimori-Yamashita J
    Int J Dermatol; 2004 Sep; 43(9):643-7. PubMed ID: 15357742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
    Loke WC; Spittle MF; Mitchell S; Kulasegaram R
    Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired immunodeficiency syndrome-related Kaposi's sarcoma: clinical features, staging, and treatment.
    Dezube BJ
    Semin Oncol; 2000 Aug; 27(4):424-30. PubMed ID: 10950369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma: an update.
    Schwartz RA
    J Surg Oncol; 2004 Sep; 87(3):146-51. PubMed ID: 15334644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatments and trials for Kaposi's sarcoma.
    Treat Rev; 1996 Aug; (No 22):11. PubMed ID: 11363814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.